Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Acta Neurochir Suppl ; 123: 177-83, 2016.
Article in English | MEDLINE | ID: mdl-27637646

ABSTRACT

INTRODUCTION: Dural arteriovenous fistulas (DAVFs) is a challenging condition in vascular neurosurgery. Development of new endovascular techniques has progressively modified treatment strategies; however, surgery is still considered a valid option of treatment of this pathology. MATERIALS AND METHODS: From a retrospective analysis of our database, we selected 107 patients who underwent surgical treatment for DAVFs. Patients were grouped into five categories according to the Borden and Cognard classifications. Patients and treatment characteristics/outcome is reported. RESULTS: At admission, 30 (28 %) patients presented with intracranial hemorrhage. Fifteen (14 %) had seizure, whereas nearly half of the patients presented with non-aggressive symptoms, including headache (10, 9.3 %), cognitive impairment (8, 7.5 %), gait disturbance, and imbalance (8, 7.5 %). The majority of patients underwent surgical treatment of fistulas; in some cases, we elected combined surgical-endovascular (obliteration) treatment. CONCLUSIONS: Management of DAVF requires a multidisciplinary assessment and treatment strategies including surgical, endovascular, and radiosurgical treatment. The data reported confirmed that surgical treatment of DAVFs is associated with a good clinical and radiological (complete occlusion of the fistula) outcome in all cases, with a low rate of complications.


Subject(s)
Endovascular Procedures/methods , Intracranial Arteriovenous Malformations/surgery , Intracranial Hemorrhages/surgery , Neurosurgical Procedures/methods , Adult , Aged , Aged, 80 and over , Angiography, Digital Subtraction , Central Nervous System Vascular Malformations/complications , Central Nervous System Vascular Malformations/diagnostic imaging , Central Nervous System Vascular Malformations/surgery , Cerebral Angiography , Computed Tomography Angiography , Databases, Factual , Female , Glasgow Outcome Scale , Headache/etiology , Humans , Intracranial Arteriovenous Malformations/complications , Intracranial Arteriovenous Malformations/diagnostic imaging , Intracranial Hemorrhages/diagnostic imaging , Intracranial Hemorrhages/etiology , Magnetic Resonance Angiography , Magnetic Resonance Imaging , Male , Middle Aged , Retrospective Studies , Seizures/etiology , Tomography, X-Ray Computed
2.
Neurol India ; 61(2): 131-7, 2013.
Article in English | MEDLINE | ID: mdl-23644311

ABSTRACT

BACKGROUND: The effectiveness of antiepileptic prophylaxis in patients with newly diagnosed high-grade glioma is debated. Craniotomy, surgical manipulation and bleeding are believed to favor the onset of seizures and, therefore, perioperative antiepileptic drugs (AEDs) are generally used. Nevertheless, evidence to initiate preoperative AED prophylaxis are weak. AIM: Aim of this paper was to evaluate the need for AED prophylaxis in surgically-treated malignant glioma patients without history of seizures. MATERIALS AND METHODS: We conducted a retrospective, two-center cohort study to assess the effectiveness of preoperative AED prophylaxis. Patients were divided in two groups: one with AED preoperative administration and the other without. Because of its non-hepatic metabolism, levetiracetam (LEV) was chosen. Logistic regression models were used to investigate the odds ratio for each group. The explanatory variables included the treatment received, sex, age, and site of lesion. The outcome measure of successful LEV prophylaxis was seizure vs. no seizure post-operatively, at three and six months after surgery. RESULTS: Our results showed that LEV prophylaxis was not a significant predictor of seizure occurrence, although the regression coefficient indicated a slight reduction in seizure risk following LEV administration. Patient's age was a significant predictor of seizure occurrence. Younger patients had a higher risk of seizure in the six months post-surgery. CONCLUSIONS: We conclude that AEDs prophylaxis does not provide a substantial benefit to surgically treated high-grade glioma patients and should not be administered routinely. Further investigations are required to detect subgroups of patients at higher risk of developing seizures in order to selectively administer AED.


Subject(s)
Anticonvulsants/therapeutic use , Brain Neoplasms/complications , Glioma/complications , Piracetam/analogs & derivatives , Seizures/prevention & control , Adult , Aged , Brain Neoplasms/surgery , Craniotomy , Female , Glioma/surgery , Humans , Levetiracetam , Male , Middle Aged , Piracetam/therapeutic use , Postoperative Period , Retrospective Studies , Seizures/drug therapy , Seizures/etiology , Treatment Outcome
3.
Neurosurg Focus ; 32(5): E11, 2012 May.
Article in English | MEDLINE | ID: mdl-22537120

ABSTRACT

The aim of this study is to review the clinical outcome of patients treated for spinal dural arteriovenous malformations and investigate the presence of pretreatment indicators of outcome after short- and midterm follow-up. The authors retrospectively reviewed the records of 65 consecutive patients treated either surgically or endovascularly in 3 neurosurgery departments between 1989 and 2009. After treatment, 80% of patients reported improvement of at least 1 symptom. Motor symptoms improved more than sensory disorders, pain, or sphincter impairment. Spinal dural arteriovenous fistulas at the thoracic level, and in particular at the lower level, responded better than those in other spinal areas. Spinal dural arteriovenous fistula is a rare pathology with a malignant course that should be treated aggressively. This study appears to confirm that neurological status before treatment, anatomical location of the fistula, and symptoms at presentation are all factors that can predict outcome. Early diagnosis of spinal dural arteriovenous malformations in the lower thoracic area in patients with an Aminoff scale score < 3 was associated with the most favorable outcome.


Subject(s)
Central Nervous System Vascular Malformations , Neurosurgery/methods , Spinal Cord Diseases , Adult , Aged , Aged, 80 and over , Angiography, Digital Subtraction , Central Nervous System Vascular Malformations/complications , Central Nervous System Vascular Malformations/diagnosis , Central Nervous System Vascular Malformations/therapy , Disability Evaluation , Female , Follow-Up Studies , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Retrospective Studies , Spinal Cord Diseases/complications , Spinal Cord Diseases/diagnosis , Spinal Cord Diseases/therapy , Treatment Outcome , Young Adult
4.
Acta Neurochir (Wien) ; 153(9): 1807-11, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21761097

ABSTRACT

BACKGROUND: A key aspect of neurosurgery is the challenge of ensuring adequate visualization through brain retraction whilst ensuring that underlying brain remains protected. Self-retaining retractors (SRR) are specially designed for this purpose. Their limitation however is the potential for ischaemic damage that accompanies any pressure on the cerebral cortex. METHODS AND TECHNIQUE: We use balloon tips of Fogarty catheters to provide gentle brain retraction during surgery for skull base and midline tumours as well as aneurysms of anterior circulation. Following completion of the craniotomy and dural opening, the balloon tip is inserted under the frontal or temporal lobes or into the interemispheric fissure, and then inflated. This results in distension of the arachnoid, thereby favouring the dissection process. CONCLUSION: Diverting the brain from operative view with a more elastic, less traumatic, and easily adjustable Fogarty catheter balloon tip is a safe and effective tool that can either act as a substitute for SRR or alternatively minimise their duration of use.


Subject(s)
Brain/surgery , Catheterization/instrumentation , Catheters/trends , Craniotomy/instrumentation , Neurosurgical Procedures/instrumentation , Skull Base/surgery , Brain/anatomy & histology , Brain/blood supply , Craniotomy/methods , Humans , Neurosurgical Procedures/methods
5.
Acta Neurochir (Wien) ; 152(11): 1835-46, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20730457

ABSTRACT

BACKGROUND: Localization of brain function is a fundamental requisite for the resection of eloquent-area brain tumors. Preoperative functional neuroimaging and diffusion tensor imaging can display cortical functional organization and subcortical anatomy of major white matter bundles. Direct cortical and subcortical stimulation is widely used in routine practice, however, because of its ability to reveal tissue function in eloquent regions. The role and integration of these techniques is still a matter of debate. The objective of this study was to assess surgical and functional neurological outputs of awake surgery and intraoperative cortical and subcortical electrical stimulation (CSES) and to use CSES to examine the reliability of preoperative functional magnetic resonance (fMRI) and diffusion tensor imaging fiber tracking (DTI-FT) for surgical planning. PATIENTS AND METHODS: We prospectively studied 27 patients with eloquent-area tumors who were selected to undergo awake surgery and direct brain mapping. All subjects underwent preoperative sensorimotor and language fMRI and DTI tractography of major white matter bundles. Intra- and postoperative complications, stimulation effects, extent of resection, and neurological outcome were determined. We topographically correlated intraoperatively identified sites (cortical and subcortical) with areas of fMRI activation and DTI tractography. RESULTS: Total plus subtotal resection reached 88.8%. Twenty-one patients (77.7%) suffered transient postoperative worsening, but at 6 months follow-up only three (11.1%) patients had persistent neurological impairment. Sensorimotor cortex direct mapping correlated 92.3% with fMRI activation, while direct mapping of language cortex correlated 42.8%. DTI fiber tracking underestimated the presence of functional fibers surrounding or inside the tumor. CONCLUSION: Preoperative brain mapping is useful when planning awake surgery to estimate the relationship between the tumor and functional brain regions. However, these techniques cannot directly lead the surgeon during resection. Intraoperative brain mapping is necessary for safe and maximal resection and to guarantee a satisfying neurological outcome. This multimodal approach is more aggressive, leads to better outcomes, and should be used routinely for resection of lesions in eloquent brain regions.


Subject(s)
Brain Mapping/methods , Brain Neoplasms/diagnosis , Diagnostic Imaging/methods , Electrodiagnosis/methods , Monitoring, Intraoperative/methods , Preoperative Care/methods , Adolescent , Adult , Brain Neoplasms/physiopathology , Brain Neoplasms/surgery , Female , Humans , Male , Middle Aged , Prospective Studies , Young Adult
6.
Neurol Med Chir (Tokyo) ; 50(5): 410-3, 2010.
Article in English | MEDLINE | ID: mdl-20505301

ABSTRACT

A 38-year-old woman presented with a large infiltrative left frontal low-grade glioma manifesting as partial seizures of the left arm and lower limb. First line chemotherapy with temozolomide reduced infiltration and volume, allowing subtotal surgical resection. The patient suffered postoperative supplementary motor area syndrome with right hemiparesis and mutism that resolved completely after approximately one month. She was able to return to her full-time job after 4 months. The residual tumor was stable, and the frequency of seizures had lessened dramatically at the last follow-up examination at 18 months. The present case demonstrates that this new therapeutic approach of chemotherapy followed by surgery can offer safer and more radical surgical resection, improving the quality of life of the patient.


Subject(s)
Antineoplastic Agents, Alkylating/therapeutic use , Astrocytoma/drug therapy , Brain Neoplasms/drug therapy , Dacarbazine/analogs & derivatives , Neoadjuvant Therapy/methods , Preoperative Period , Adult , Astrocytoma/pathology , Astrocytoma/surgery , Brain Neoplasms/pathology , Brain Neoplasms/surgery , Chemotherapy, Adjuvant , Corpus Callosum/pathology , Dacarbazine/therapeutic use , Female , Frontal Lobe/pathology , Functional Laterality , Humans , Motor Cortex/pathology , Temozolomide , Treatment Outcome
7.
Neurosurg Rev ; 33(3): 297-303; discussion 303-4, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20437070

ABSTRACT

The aim of this study was to analyze the long-term clinical and radiological outcomes of craniocervical decompression for patients affected by Chiari I-related syringomyelia. We performed a retrospective analysis of a group of patients affected by Chiari I-associated syringomyelia treated by craniocervical decompression (CCD). Surgical and technical aspects and preoperative factors predicting outcome were discussed. A total of 36 patients were reviewed. There were 17 men and 19 women (female/male ratio 1.11), and the mean age was 40.4 (range 18-68). The most important preoperative symptoms were related to myelopathy (pain, weakness, atrophy, spasticity, sensory loss, and dysesthesias). Most syrinxes were in the cervico-thoracic region (61.1%), and the majority of patients had tonsillar descent between the foramen magnum and C1. All patients underwent a craniectomy less than 3 cm in diameter followed by a duroplasty with dura substitute. No arachnoid manipulation was necessary. Three patients (8.1%) experienced cerebrospinal fluid leaks that resolved without complications. At a mean follow up of 40 months (range 16-72) 80.5% of patients exhibited improvement over their preoperative neurological examination while 11.1% stabilized. The syrinx shrank in 80.5% of patients. Chi-square test showed that preoperative syrinx extension and degree of tonsillar descent did not correlate with clinical and neuroradiological postoperative evolution. Treating syringomyelia associated in Chiari I malformation with CCD leads to a large percentage of patients with satisfying results and no irreversible complications.


Subject(s)
Arnold-Chiari Malformation/complications , Arnold-Chiari Malformation/surgery , Decompression, Surgical , Neurosurgical Procedures , Syringomyelia/etiology , Syringomyelia/surgery , Adolescent , Adult , Aged , Arnold-Chiari Malformation/diagnostic imaging , Dura Mater/surgery , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Postoperative Complications/pathology , Radiography , Spine/surgery , Syringomyelia/diagnostic imaging , Treatment Outcome , Young Adult
8.
Neurosurgery ; 55(4): 815-22; discussion 822-3, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15458589

ABSTRACT

OBJECTIVE: The outcome of treatment for a spinal dural arteriovenous fistula is unpredictable. In this study, we reviewed the outcome of patients treated for this condition, in relation to pretreatment indicators. METHODS: We reviewed the records of 37 consecutive patients treated either surgically or endovascularly in our department between 1989 and 2002. RESULTS: At follow-up, 78% of the patients reported improvement. Those with motor symptoms had the best outcome: improvement was achieved in more than 60% of the patients, amounting to 1 or 2 points on the Aminoff scale. Sensory disorders improved in 43% of cases, pain in 61%, and sphincter impairment in only 37%. Patients with a fistula in the lower thoracic region did better than those with fistulae in other locations. CONCLUSION: The clinical state before treatment is certainly relevant in predicting outcome. Age and duration of the symptoms before treatment have no direct relation to the chances of improvement with treatment, particularly when motor improvement is considered. The modality of onset of symptoms and location of the fistula play significant roles, also: a fistula in the lower thoracic segment was associated with more severe symptoms but tended to improve more (83%, P = 0.04) after treatment. Midthoracic and lumbar fistulae showed a lower incidence of improvement (<50%).


Subject(s)
Central Nervous System Vascular Malformations/surgery , Central Nervous System Vascular Malformations/therapy , Adult , Aged , Disability Evaluation , Dura Mater/pathology , Dura Mater/surgery , Embolization, Therapeutic/methods , Female , Humans , Male , Middle Aged , Neurosurgical Procedures/methods , Spinal Cord/blood supply , Spinal Cord/pathology , Spinal Cord/surgery , Spinal Cord Diseases/surgery , Spinal Cord Diseases/therapy , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...